Product Description
| Cat Number | PI-040 |
|---|---|
| Category | Peptide |
| Pack Size | 10 mg |
| Description | Serine protease inhibitor |
| Purity | >98% by HPLC |
| Biomarker Target | Serine proteases,Other proteases |
| Sequence Three Letter Code | 4-[(Aminoiminomethyl)amino]benzoic acid 6-(aminoiminomethyl)-2-naphthalenyl ester dimethanesulfonate |
| Molecular Formula | C19H17N5O2.2CH4O3S |
| Sl Sequence | 4-[(Aminoiminomethyl)amino]benzoic acid 6-(aminoiminomethyl)-2-naphthalenyl ester dimethanesulfonate |
| Solubility | Soluble to 100 mM in water |
| Appearance | White solid |
| Storage | Store desiccated, frozen and in the dark |
| References |
Sendo et al (2003) A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium. Br. J. Pharmacol. 138 959 PMID: 12642398Chen et al (2006) Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma. J. Allergy Clin. Immunol. 118 105 PMID: 16815145Wang et al (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30(3) 269 PMID: 32020029 Related areas_x000D_ All small molecules >All serine protease modulators >All antiviral agents >All cancer research categories > |
| Note | The product is for research use only |
Share Item: